Penerbitan Terkini

amnani aminuddin, pei yuen ng, chee onn leong, eng wee chua.  (2020).  mitochondrial dna alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma.  - scientific reports.  1-17. 

muhammad taufik suaidi, poh kuan wong, nurul ain mohd tahir, and eng wee chua.  (2020).  community pharmacists' knowledge, attitude, and practice in providing self-care recommendations for the management of premenstrual syndrome.  - medicina.  1-16. 

simone l. cree, eng wee chua, jennifer crowther, renwick c.j. dobson, martin a. kennedy.  (2020).  g-quadruplex structures bind to ez-tn5 transposase.  - biochimie.  190-197. 

ng shiow fern;jamia azdina binti jamal;malina binti jasamai;haliza katas;noraida binti mohamed shah;ernieda binti md hatah;marhanis salihah binti omar;norsyahida binti mohd fauzi;chong wei wen;tuan mazlelaa binti tuan mahmood;chua eng wee;lam kok wai.  (2019).  pembangunan gamifikasi untuk pengajaran dan pembelajaran amalan farmasi secara kendiri.  -

chua eng wee;norfilza binti mohd mokhtar;mohd bin makmor bakry;raja affendi bin raja ali;ng pei yuen.  (2019).  thiopurine metabolites in inflammatory bowel disease: optimising correlation with disease activity and identification of novel genetic factors that govern treatment outcome.  -

eng wee chua, simon p. harger, martin a. kennedy.  (2019).  metoclopramide-induced acute dystonic reactions may be associated with the cyp2d6 poor metaboliser status and pregnancy-related hormonal changes.  - frontiers in pharmacology.  1-5. 

eng wee chua, chian siang goh.  (2019).  benchmarking in silico tools for the functional assessment of dna variants using a set of strictly pharmacogenetic variants.  - sains malaysiana.  2151-2159. 

wan nur husnul khatimah wan mansor, eng wee chua.  (2019).  optimising long pcr: efficacy of pcr additives.  - 2nd mypsa national pharmacy research competition 2019: renaissance: the art of creative thinking.  1-2. 

sheng zhang lim, eng wee chua.  (2018).  revisiting the role of thiopurines in inflammatory bowel disease through pharmacogenomics and use of novel methods for therapeutic drug monitoring.  - frontiers in pharmacology. 

chua eng wee.  (2018).  recurrent aphthous ulcers ii.  - china press. 

chua eng wee.  (2018).  deadly genes.  - china press. 

norazrina azmi, nor syafinaz yaakob, malina jasamai, eng wee chua.  (2018).  crossover learning through a health campaign integrated in a bachelor of pharmacy curriculum.  - asean journal of teaching and learning in higher education. 

bai hui tiang, raja affendi raja ali, norfilza mohd mokhtar, and eng wee, chua.  (2018).  association between 6-tgn levels and remission of ibd in asian patients: a meta-analysis.  - simposium kebangsaan penyelidikan perubatan dan kesihatan & minggu penyelidikan ke-20. 

amnani aminuddin, pei yuen ng, chee onn leong, and eng wee chua.  (2018).  influence of mitochondrial dna alterations on cisplatin chemoresistance in oral squamous cell carcinoma.  - international conference on drug discovery and translational medicine 2018 (icddtm 18) seizing opportunities and addressing challenges of precision medicine. 

eng wee chua.  (2018).  precision medicine.  - china press. 

eng wee chua.  (2018).  use of fish oils in childhood asthma.  - china press. 

simran ds maggo, eng wee chua, paul chin, simone cree, john pearson, matt doogue, martin a kennedy.  (2017).  a new zealand platform to enable genetic investigation of adverse drug reactions.  - new zealand medical journal.  62-69. 

eng wee chua, simran maggo, martin a. kennedy.  (2017).  pcr methods and protocols.  - 10. 

eng wee chua, hon shen wong.  (2017).  an overview of the management of eczema.  - mims pharmacy.  8-10. 

m.a. kennedy, s.d.s. maggo, j. foulds, s. luty, e.w. chua, s. cree, k. ton, y. liau, a.l. miller, p. chin, k. lehnert, m. doogue.  (2017).  dna banking and genetic analysis of adverse drug reactions in the new zealand healthcare setting.  - ashg 2017 annual meeting.  879. 

chua eng wee, ng pei yuen.  (2016).  minion: a novel tool for predicting drug hypersensitivity?.  - frontiers in pharmacology.  1-7. 

eng wee chua, simone l. cree, kim n. t. ton, klaus lehnert, phillip shepherd, nuala helsby, martin a. kennedy.  (2016).  cross-comparison of exome analysis, next-generation sequencing of amplicons, and the iplex adme pgx panel for pharmacogenomic profiling.  - frontiers in pharmacology.  1-7. 

chua eng wee.  (2016).  transforming pharmacogenetics: dna sequencing technologies.  - impact.  10. 

eng wee chua, simone cree, murray l. barclay, kit doudney, alan aitchison, martin a. kennedy.  (2015).  exome sequencing and array-based comparative genomic hybridisation analysis of preferential 6-methylmercaptopurine producers.  - the pharmacogenomics journal.  414-421. 

eng wee chua, allison l. miller, martin a. kennedy.  (2015).  choice of pcr microtube can impact on the success of long-range pcrs.  - analytical biochemistry.  115-117. 

endang kumolosasi, gan boon yan and chua eng wee.  (2015).  efficacy of some combination regimens of oral hypoglycaemic agents in type 2 diabetes mellitus patients.  - tropical journal of pharmaceutical research.  1279-1284. 

eng wee chua, james foulds, allison l. miller, martin a. kennedy.  (2013).  novel cyp2d6 and cyp2c19 variants identified in a patient with adverse reactions towards venlafaxine monotherapy and dual therapy with nortriptyline and fluoxetine.  - pharmacogenetics and genomics.  494-497. 

e kumolosasi, wong sin wei, chua eng wee.  (2013).  the use of thrombolytic agents in acute myocardial infarction (ami) patients.  - international journal of pharmacy and pharmaceutical sciences.  5(2):63-67. 

trent, r.j., cheong, p.l., chua, e.w., kennedy, m.a..  (2013).  progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.  - pathology.  45(4):357-370. 

e.w. chua and m.a. kennedy.  (2012).  current state and future prospects of direct-to-consumer pharmacogenetics.  - frontiers in pharmacology.  3:1-8. 

cheang cheng ye, endang kumolosasi* and chua eng wee.  (2012).  n-acetylcysteine for prevention of iodinated contrast-induced nephropathy in computed tomography angiography procedures in patients with chronic kidney disease.  - african journal of pharmacy and pharmacology.  6(3):181-189.